# Perioperative Sitagliptin Medication for Reduction of the Inflammatory Response Associated With Cardiopulmonary Bypass

> **NCT05725798** · — · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 20 (actual)

## Conditions studied

- Systemic Inflammatory Response Syndrome

## Interventions

- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT05725798
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-08-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05725798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05725798, "Perioperative Sitagliptin Medication for Reduction of the Inflammatory Response Associated With Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05725798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*